Transfusion Therapy in Postpartum Hemorrhage

Seminars in Perinatology

Volumn 33, Issue 2, 2009, Pages 124-127

  Padmanabhan, Anand ^a   Schwartz, Joseph ^a   Spitalnik, Steven L ^a  

^a New York Presbyterian Morgan Stanley Children's Hospital   (United States)

Author keywords

blood transfusion; dilution coagulopathy; disseminated intra vascular coagulation; factor VII; hemorrhage protocol; postpartum hemorrhage

Indexed keywords

PLACEBO; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ARTERY EMBOLISM; BLOOD CLOTTING FACTOR 7 DEFICIENCY; CESAREAN SECTION; CRYOPRECIPITATE; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG MECHANISM; DRUG MEGADOSE; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; HEREDITARY HEMOLYTIC ANEMIA; HUMAN; HYSTERECTOMY; LOW DRUG DOSE; OBSTETRIC EMERGENCY; PLASMA TRANSFUSION; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; REVIEW; THROMBOCYTE TRANSFUSION; THROMBOEMBOLISM; UNSPECIFIED SIDE EFFECT; VAGINAL DELIVERY;

BLOOD COAGULATION FACTORS; BLOOD COMPONENT TRANSFUSION; DISSEMINATED INTRAVASCULAR COAGULATION; FACTOR VIIA; FEMALE; HUMANS; POSTPARTUM HEMORRHAGE; PREGNANCY; RECOMBINANT PROTEINS;

EID: 62749126711     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semperi.2009.01.002     Document Type: Review

References (57)

1. AbouZahr C. Safe motherhood: A brief history of the global movement 1947-2002. Br Med Bull 67 (2003) 13-25
2. ACOG Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists Number 76, October 2006: postpartum hemorrhage. Obstet Gynecol 108 (2006) 1039-1047
3. Shevell T., and Malone F.D. Management of obstetric hemorrhage. Semin Perinatol 27 (2003) 86-104
4. Franchini M. Haemostasis and pregnancy. Thromb Haemost 95 (2006) 401-413
5. Lockwood C.J. Regulation of plasminogen activator inhibitor 1 expression by interaction of epidermal growth factor with progestin during decidualization of human endometrial stromal cells. Am J Obstet Gynecol 184 (2001) 798-804 discussion 804-795
6. Lockwood C.J., Krikun G., and Schatz F. The decidua regulates hemostasis in human endometrium. Semin Reprod Endocrinol 17 (1999) 45-51
7. Lockwood C.J., and Schatz F. A biological model for the regulation of peri-implantational hemostasis and menstruation. J Soc Gynecol Investig 3 (1996) 159-165
8. ACOG Educational Bulletin: Postpartum Hemorrhage. Number 243, January 1998 (replaces No. 143, July 1990). American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 61 (1998) 79-86
9. Combs C.A., Murphy E.L., and Laros Jr. R.K. Factors associated with postpartum hemorrhage with vaginal birth. Obstet Gynecol 77 (1991) 69-76
10. Bonnar J. Massive obstetric haemorrhage. Baillieres Best Pract Res Clin Obstet Gynaecol 14 (2000) 1-18
11. Murphy M.F., Wallington T.B., Kelsey P., et al. Guidelines for the clinical use of red cell transfusions. Br J Haematol 113 (2001) 24-31
12. Petersen L.A., Lindner D.S., Kleiber C.M., et al. Factors that predict low hematocrit levels in the postpartum patient after vaginal delivery. Am J Obstet Gynecol 186 (2002) 737-744
13. Weiskopf R.B., Viele M.K., Feiner J., et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 279 (1998) 217-221
14. Platelet transfusion therapy. National Institutes of Health Consensus Conference. Transfus Med Rev 1 (1987) 195-200
15. Hellstern P., and Haubelt H. Indications for plasma in massive transfusion. Thromb Res 107 suppl 1 (2002) S19-S22
16. AuBuchon J. Hemotherapy decisions and their outcomes. In: Roback J.D., Combs M.R., Grossman B.J., and Hillyer C.D. (Eds). Technical Manual. (Ed 16) (2008), AABB, Bethesda, MD 569-624
17. Faringer P.D., Mullins R.J., Johnson R.L., et al. Blood component supplementation during massive transfusion of AS-1 red cells in trauma patients. J Trauma 34 (1993) 481-485
18. Hiippala S. Replacement of massive blood loss. Vox Sang 74 suppl 2 (1998) 399-407
19. Hirshberg A., Dugas M., Banez E.I., et al. Minimizing dilutional coagulopathy in exsanguinating hemorrhage: A computer simulation. J Trauma 54 (2003) 454-463
20. Lundsgaard-Hansen P. Treatment of acute blood loss. Vox Sang 63 (1992) 241-246
21. Smetannikov Y., and Hopkins D. Intraoperative bleeding: A mathematical model for minimizing hemoglobin loss. Transfusion 36 (1996) 832-835
22. Ho A.M., Dion P.W., Cheng C.A., et al. A mathematical model for fresh frozen plasma transfusion strategies during major trauma resuscitation with ongoing hemorrhage. Can J Surg 48 (2005) 470-478
23. Stinger H.K., Spinella P.C., Perkins J.G., et al. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma 64 (2008) S79-S85 discussion S85
24. Borgman M.A., Spinella P.C., Perkins J.G., et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 63 (2007) 805-813
25. Engstrom M., Schott U., Romner B., et al. Acidosis impairs the coagulation: A thromboelastographic study. J Trauma 61 (2006) 624-628
26. Cosgriff N., Moore E.E., Sauaia A., et al. Predicting life-threatening coagulopathy in the massively transfused trauma patient: Hypothermia and acidoses revisited. J Trauma 42 (1997) 857-861 discussion 861-862
27. DeLoughery T.G. Coagulation defects in trauma patients: Etiology, recognition, and therapy. Crit Care Clin 20 (2004) 13-24
28. Ferrara A., MacArthur J.D., Wright H.K., et al. Hypothermia and acidosis worsen coagulopathy in the patient requiring massive transfusion. Am J Surg 160 (1990) 515-518
29. Weiner C.P. The obstetric patient and disseminated intravascular coagulation. Clin Perinatol 13 (1986) 705-717
30. Levi M. Disseminated intravascular coagulation. Crit Care Med 35 (2007) 2191-2195
31. Levi M., de Jonge E., and van der Poll T. Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation. Crit Care Med 29 (2001) S90-S94
32. Levi M., van der Poll T., ten Cate H., et al. The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia. Eur J Clin Invest 27 (1997) 3-9
33. Levi M., de Jonge E., van der Poll T., et al. Disseminated intravascular coagulation. Thromb Haemost 82 (1999) 695-705
34. Bakhtiari K., Meijers J.C., de Jonge E., et al. Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 32 (2004) 2416-2421
35. Dempfle C.E., Wurst M., Smolinski M., et al. Use of soluble fibrin antigen instead of D-dimer as fibrin-related marker may enhance the prognostic power of the ISTH overt DIC score. Thromb Haemost 91 (2004) 812-818
36. http://www.novomedlink.com/products/NovoSeven-RT/novoseven-rt-home.aspx Accessed December 26, 2008
37. Mayer S.A., Brun N.C., Begtrup K., et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 358 (2008) 2127-2137
38. Beekley A.C. Damage control resuscitation: A sensible approach to the exsanguinating surgical patient. Crit Care Med 36 (2008) S267-S274
39. Moscardo F., Perez F., de la Rubia J., et al. Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. Br J Haematol 114 (2001) 174-176
40. Bouwmeester F.W., Jonkhoff A.R., Verheijen R.H., et al. Successful treatment of life-threatening postpartum hemorrhage with recombinant activated factor VII. Obstet Gynecol 101 (2003) 1174-1176
41. Price G., Kaplan J., and Skowronski G. Use of recombinant factor VIIa to treat life-threatening non-surgical bleeding in a post-partum patient. Br J Anaesth 93 (2004) 298-300
42. Ahonen J., and Jokela R. Recombinant factor VIIa for life-threatening post-partum haemorrhage. Br J Anaesth 94 (2005) 592-595
43. Haynes J., Laffan M., and Plaat F. Use of recombinant activated factor VII in massive obstetric haemorrhage. Int J Obstet Anesth 16 (2007) 40-49
44. Franchini M., Lippi G., and Franchi M. The use of recombinant activated factor VII in obstetric and gynaecological haemorrhage. Br J Obstet Gynaecol 114 (2007) 8-15
45. Prosper S.C., Goudge C.S., and Lupo V.R. Recombinant factor VIIa to successfully manage disseminated intravascular coagulation from amniotic fluid embolism. Obstet Gynecol 109 (2007) 524-525
46. Hedner U. Factor VIIa and its potential therapeutic use in bleeding-associated pathologies. Thromb Haemost 100 (2008) 557-562
47. Viuff D., Lauritzen B., Pusateri A.E., et al. Effect of haemodilution, acidosis, and hypothermia on the activity of recombinant factor VIIa (NovoSeven). Br J Anaesth 101 (2008) 324-331
48. Hall K., Forrest P., and Sawyer C. The effects of acidosis and hypothermia on blood transfusion requirements following factor VII administration. Anaesthesiol Intens Care 35 (2007) 494-497
49. Rizoli S.B., Nascimento Jr. B., Osman F., et al. Recombinant activated coagulation factor VII and bleeding trauma patients. J Trauma 61 (2006) 1419-1425
50. Wu S., Kocherginsky M., and Hibbard J.U. Abnormal placentation: Twenty-year analysis. Am J Obstet Gynecol 192 (2005) 1458-1461
51. Hatfield J.L., Brumsted J.R., and Cooper B.C. Conservative treatment of placenta accreta. J Minim Invasive Gynecol 13 (2006) 510-513
52. Kruskall M.S., Leonard S., and Klapholz H. Autologous blood donation during pregnancy: Analysis of safety and blood use. Obstet Gynecol 70 (1987) 938-941
53. Herbert W.N., Owen H.G., and Collins M.L. Autologous blood storage in obstetrics. Obstet Gynecol 72 (1988) 166-170
54. Monk T.G. Acute normovolemic hemodilution. Anesthesiol Clin North Am 23 (2005) 271-281 vi
55. Hudon L., Belfort M.A., and Broome D.R. Diagnosis and management of placenta percreta: A review. Obstet Gynecol Surv 53 (1998) 509-517
56. Rebarber A., Lonser R., Jackson S., et al. The safety of intraoperative autologous blood collection and autotransfusion during Cesarian section. Am J Obstet Gynecol 179 (1998) 715-720
57. Gyamfi C., Gyamfi M.M., and Berkowitz R.L. Ethical and medicolegal considerations in the obstetric care of a Jehovah's witness. Obstet Gynecol 102 (2003) 173-180